Media coverage about K2M Group (NASDAQ:KTWO) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. K2M Group earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave headlines about the medical device company an impact score of 45.4053237686913 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Several equities research analysts have recently commented on the stock. Cowen set a $28.00 target price on shares of K2M Group and gave the company a “buy” rating in a research note on Thursday, August 17th. Zacks Investment Research upgraded shares of K2M Group from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research note on Wednesday, October 4th. Needham & Company LLC restated a “strong-buy” rating and issued a $27.00 target price (down previously from $29.00) on shares of K2M Group in a research note on Monday, October 9th. They noted that the move was a valuation call. Royal Bank Of Canada restated a “buy” rating and issued a $26.00 target price on shares of K2M Group in a research note on Friday, September 22nd. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $28.00 target price on shares of K2M Group in a research note on Thursday, September 28th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $25.00.
K2M Group (NASDAQ:KTWO) opened at $17.08 on Friday. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 0.29. K2M Group has a twelve month low of $17.06 and a twelve month high of $25.99.
K2M Group (NASDAQ:KTWO) last released its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.01). K2M Group had a negative net margin of 16.22% and a negative return on equity of 16.02%. The business had revenue of $62.65 million during the quarter, compared to the consensus estimate of $62.69 million. During the same period in the prior year, the firm earned ($0.19) earnings per share. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. analysts predict that K2M Group will post -0.86 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://ledgergazette.com/2017/12/08/k2m-group-ktwo-given-daily-coverage-optimism-score-of-0-14.html.
K2M Group Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.